Unchained Labs adds nanoparticle characterization suite

By The Science Advisory Board staff writers

July 2, 2021 -- Unchained Labs has launched a new application suite for the characterization of nanoparticles on Stunner, the company's gene therapy platform.

Stunner simultaneously quantifies nanoparticle payloads and measures their size distribution, two critical qualities necessary for an effective nanoparticle vaccine or gene therapy, Unchained said. Moreover, it uses only 2 µL of each sample and performs label-free.

Currently, Stunner provides a method for adeno-associated viruses (AAV) titer and empty/full ratio measurements.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.